ArticleSurgery today2022

A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer.

Takaaki Arigami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.